Literature DB >> 18030499

Arterial thrombosis associated with factor V Leiden and methylenetetrahydrofolate reductase C677T mutation in childhood membranous glomerulonephritis.

Mithat Büyükçelik1, Metin Karakök, Osman Başpinar, Ayşe Balat.   

Abstract

Acquired abnormalities of coagulation and fibrinolysis in nephrotic syndrome have been implicated in the pathogenesis of deep-vein and arterial thrombosis. A mutation in the factor V and methylenetetrahydrofolate reductase (MTHFR) gene, the commonest inherited risk factor for venous thrombosis, may contribute to the risk of both arterial and deep-vein thrombosis in patients with nephrotic syndrome. Here, we report on an arterial thrombosis in a young girl with idiopathic membranous glomerulonephritis associated with heterozygous factor V Leiden and homozygous MTHFR C677T mutation. We postulate that screening for factors such as factor V Leiden and MTHFR C677T mutation may be beneficial to patients associated with thromboembolism and idiopathic nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030499     DOI: 10.1007/s00467-007-0657-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.

Authors:  J D Torres; H Cardona; L Alvarez; W Cardona-Maya; S A Castañeda; F Quintero-Rivera; A Cadavid; G Bedoya; L Tobón
Journal:  Am J Hematol       Date:  2006-12       Impact factor: 10.047

Review 2.  Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.

Authors:  F Llach
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

3.  Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

Authors:  J Voorberg; J Roelse; R Koopman; H Büller; F Berends; J W ten Cate; K Mertens; J A van Mourik
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

Review 4.  Epidemiology of venous thromboembolic disease.

Authors:  V Kim; J Spandorfer
Journal:  Emerg Med Clin North Am       Date:  2001-11       Impact factor: 2.264

5.  World distribution of factor V Leiden.

Authors:  D C Rees; M Cox; J B Clegg
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

6.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

7.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

8.  Inherited risk factors for thrombophilia in children with nephrotic syndrome.

Authors:  D Fabri; V M Belangero; J M Annichino-Bizzacchi; V R Arruda
Journal:  Eur J Pediatr       Date:  1998-11       Impact factor: 3.183

9.  Thrombotic complications in childhood-onset idiopathic membranous nephropathy.

Authors:  Chrystal U Louis; Bruce Z Morgenstern; Lavjay Butani
Journal:  Pediatr Nephrol       Date:  2003-10-30       Impact factor: 3.714

10.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  2 in total

1.  Renal infarction and rapidly progressive arterial thromboembolism following a percutaneous renal biopsy.

Authors:  Sungjin Chung; Cheol Whee Park; Yoon Sik Chang
Journal:  BMJ Case Rep       Date:  2009-09-09

2.  Childhood Nephrotic Syndrome Complicated by Catastrophic Multiple Arterial Thrombosis Requiring Bilateral Above-Knee Amputation.

Authors:  Hayato Togashi; Yuko Shimosato; Ken Saida; Noriko Miyake; Takeshi Nakamura; Shuichi Ito
Journal:  Front Pediatr       Date:  2020-03-19       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.